Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03511534 · ClinicalTrials.gov registry record · NA

Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder

A NA study of OCD, sponsored by Stanford University.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT03511534 is a NA study of OCD that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 200 participants, below the 807-participant average among 18 other OCD trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03511534, a NA study of OCD, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Psychotherapy
  • OTHER Pharmacotherapy

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2017-06-23
Est. Completion 2026-06
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03511534

The ClinicalTrials.gov registry entry for NCT03511534 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 807-participant average among 18 other OCD trials with a reported enrollment target (75% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 2 interventions - of which Psychotherapy is the first listed.

NCT03511534 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03511534 about?

NCT03511534 is a clinical study titled "Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder". The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.

What is the current status of trial NCT03511534?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2017-06-23. Estimated completion is 2026-06.

What conditions does trial NCT03511534 study?

This clinical trial studies the following conditions: OCD.

What interventions are being tested in trial NCT03511534?

The interventions under investigation include: Psychotherapy (BEHAVIORAL), Pharmacotherapy (OTHER).

Who is sponsoring clinical trial NCT03511534?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03511534 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for OCD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.